Induction of murine thyroiditis by a non dominant Ek-restricted peptide of human thyroglobulin

Immunology

Volumn 108, Issue 4, 2003, Pages 556-561

  Karras, Evangelos ^a   Carayanniotis, George ^a,b   Lymberi, Peggy ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PEPTIDE DERIVATIVE; PROLYLTYROSYLGLUTAMYLPHENYLALANYLSERYLARGINYLLYSYLVALYLPROLYLTHREONYLPHENYL ALANYLALANYLTHREONYLPROLYLTRYPTOPHYLPROLYLASPARTYLPHENYLALANYLVALYLPROLINE; THYROGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HASHIMOTO DISEASE; IMMUNOGENICITY; LYMPH NODE CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; LYMPH NODES; MICE; MICE, INBRED AKR; PEPTIDE FRAGMENTS; TH1 CELLS; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 0037394421     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01607.x     Document Type: Article

References (33)

1. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994; 15:788-830.
2. Shulman S. Thyroid antigens and autoimmunity. Adv Immunol 1971; 14:85-185.
3. van de Graaf SA, Ris-Stalpers C, Pauws E, Mendive FM, Targovnik HM, de Vijlder JJ. Up to date with human thyroglobulin. J Endocrinol 2001; 170:307-21.
4. Carayanniotis G, Rao VP. Searching for pathogenic epitopes in thyroglobulin: parameters and caveats. Immunol Today 1997; 18:83-8.
5. Mappouras DG, Philippou G, Haralambous S, Tzartos SJ, Balafas A, Souvatzoglou A, Lymberi P. Antibodies to acetylcholinesterase cross-reacting with thyroglobulin in myasthenia gravis and Graves's disease. Clin Exp Immunol 1995; 100:336-43.
6. Swillens S, Ludgate M, Mercken L, Dumont JE, Vassart G. Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase: possible functional and clinical significance. Biochem Biophys Res Commun 1986; 137:142-8.
7. Maron R, Zerubavel R, Friedman A, Cohen IR. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol 1983; 131:2316-22.
8. Romball CG, Weigle WO. Transfer of experimental autoimmune thyroiditis with T cell clones. J Immunol 1987; 138:1092-8.
9. Vladutiu AO, Rose NR. Cellular basis of the genetic control of immune responsiveness to murine thyroglobulin in mice. Cell Immunol 1975; 17:106-13.
10. Thrasyvoulides A, Sakarellos-Daitsiotis M, Philippou G, Souvatzoglou A, Sakarellos C, Lymberi P. B-cell autoepitopes on the acetylcholinesterase-homologous region of human thyroglobulin: association with Graves' disease and thyroid eye disease. Eur J Endocrinol 2001; 145:119-27.
11. Altuvia Y, Berzofsky JA, Rosenfeld R, Margalit H. Sequence features that correlate with MHC restriction. Mol Immunol 1994; 31:1-19.
12. Leighton J, Sette A, Sidney J, Appella E, Ehrhardt C, Fuchs S, Adorini L. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells. J Immunol 1991; 147:198-204.
13. Rao VP, Balasa B, Carayanniotis G. Mapping of thyroglobulin epitopes: presentation of a 9mer pathogenic peptide by different mouse MHC class II isotypes. Immunogenetics 1994; 40:352-9.
14. Vladutiu AO, Rose NR. Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science 1971; 174:1137-9.
15. Schardt CW, McLachlan SM, Matheson J, Smith BR. An enzyme-linked immunoassay for thyroid microsomal antibodies. J Immunol Methods 1982; 55:155-68.
16. Malthiery Y, Lissitzky S. Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biochem 1987; 165:491-8.
17. Oi VT, Jones PP, Goding JW, Herzenberg LA, Herzenberg LA. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol 1978; 81:115-20.
18. Ozato K, Mayer N, Sachs DH. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 1980; 124:533-40.
19. Chronopoulou E, Carayanniotis G. Identification of a thyroiditogenic sequence within the thyroglobulin molecule. J Immunol 1992; 149:1039-44.
20. Beisel KW, David CS, Giraldo AA, Kong YM, Rose NR. Regulation of experimental autoimmune thyroiditis: mapping of susceptibility to the I-A subregion of the mouse H-2. Immunogenetics 1982; 15:427-30.
21. Carayanniotis G, Kong YC. Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis. Int Rev Immunol 2000; 19:557-72.
22. Gammon G, Shastri N, Cogswell J, Wilbur S, Sadegh-Nasseri S, Krzych U, Miller A, Sercarz E. The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol Rev 1987; 98:53-73.
23. Carayanniotis G, Chronopoulou E, Rao VP. Distinct genetic pattern of mouse susceptibility to thyroiditis induced by a novel thyroglobulin peptide. Immunogenetics 1994; 39:21-8.
24. Voorby HA, Kabel PJ, de Haan M, Jeucken PH, van der Gaag RD, de Baets MH, Drexhage HA. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clin Immunol Immunopathol 1990; 55:9-22.
25. Anderton SM, Viner NJ, Matharu P, Lowrey PA, Wraith DC. Influence of a dominant cryptic epitope on autoimmune T cell tolerance. Nat Immunol 2002; 3:175-81.
26. Thompson C, Farid NR. Post-partum thyroiditis and goitrous (Hashimoto's) thyroiditis are associated with HLA-DR4. Immunol Lett 1985; 11:301-3.
27. Badenhoop K, Schwarz G, Walfish PG, Drummond V, Usadel KH, Bottazzo GF. Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 1990; 71:1131-7.
28. Sette A, Sidney J, Oseroff C et al. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol 1993; 151:3163-70.
29. Dai Y, Carayanniotis KA, Eliades P, Lymberi P, Shepherd P, Kong Y, Carayanniotis G. Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin. J Immunol 1999; 162:6987-92.
30. Dai YD, Rao VP, Carayanniotis G. Enhanced iodination of thyroglobulin facilitates processing and presentation of a cryptic pathogenic peptide. J Immunol 2002; 168:5907-11.
31. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358:155-7.
32. Rao VP, Kajon AE, Spindler KR, Carayanniotis G. Involvement of epitope mimicry in potentiation but not initiation of autoimmune disease. J Immunol 1999; 162:5888-93.
33. Verginis P, Stanford MM, Carayanniotis G. Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditis. J Immunol 2002; 169:5332-7.